Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Application of the Family-Centered Empowerment Model in an Intervention to Reduce Burden Among Primary Caregivers of Patients With Hip Fracture

Caring for a family member after a hip fracture can place physical, emotional, social, and financial demands on the main caregiver. This study evaluates whether a support program based on the Family-Centered Empowerment Model can reduce caregiver burden compared with usual care. The program helps caregivers understand care needs, develop practical skills, build confidence, and involve other family members in caregiving.

The study plans to include 80 adult family caregivers of patients with hip fracture at one hospital in China, with 40 caregivers in each group. Group assignment depends on the enrollment period rather than chance. Caregivers enrolled during the earlier period receive usual orthopedic care guidance and follow-up. Those enrolled during the later period receive the same usual care plus the empowerment program, including education, practical skills training, family discussions, and support after discharge.

Caregivers complete questionnaires near the patient's hospital admission, at discharge, and at 1 and 3 months after discharge. The main outcome is caregiver burden, meaning the strain and difficulties associated with providing care. Other outcomes include confidence in managing challenges, self-esteem, and caregiving-related quality of life. Patient complications and hospital readmissions are also recorded. The study will assess whether adding the empowerment program improves these outcomes.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Caring for a family member after a hip fracture can place physical, emotional, social, and financial demands on the main caregiver. This study evaluates whether a support program based on the Family-Centered Empowerment Model can reduce caregiver burden compared with usual care. The program helps caregivers understand care needs, develop practical skills, build confidence, and involve other family members in caregiving.

The study plans to include 80 adult family caregivers of patients with hip fracture at one hospital in China, with 40 caregivers in each group. Group assignment depends on the enrollment period rather than chance. Caregivers enrolled during the earlier period receive usual orthopedic care guidance and follow-up. Those enrolled during the later period receive the same usual care plus the empowerment program, including education, practical skills training, family discussions, and support after discharge.

Caregivers complete questionnaires near the patient's hospital admission, at discharge, and at 1 and 3 months after discharge. The main outcome is caregiver burden, meaning the strain and difficulties associated with providing care. Other outcomes include confidence in managing challenges, self-esteem, and caregiving-related quality of life. Patient complications and hospital readmissions are also recorded. The study will assess whether adding the empowerment program improves these outcomes.

Tipo di studio

Interventistico

Iscrizione (Stimato)

80

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Inclusion Criteria:
  • A family member serving as the primary caregiver of a patient with hip fracture aged 18 years or older.
  • Has provided care for at least 3 months and provides care for at least 8 hours per day.
  • Receives no remuneration for caregiving.
  • Able to read and communicate.
  • Willing to participate in the study and provide informed consent.

Exclusion Criteria:

  • A history of psychiatric illness.
  • Clinically diagnosed visual or hearing impairment that cannot be corrected with glasses, hearing aids, or other usual assistive devices and prevents the caregiver from reading study materials, participating in group discussions, or receiving study instructions. Age-related presbyopia or mild hearing loss that can be adequately corrected with assistive devices does not constitute an exclusion criterion.

Exclusion Criteria:

-

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Usual Orthopedic Care

Primary family caregivers of patients with hip fracture receive usual orthopedic care guidance and routine follow-up. This includes education on hip fracture and rehabilitation during hospital days 1-2, guidance on home caregiving before discharge, and weekly telephone or WeChat follow-up after discharge. Follow-up continues through 3 months after discharge.

Usual orthopedic care guidance and follow-up are provided to primary family caregivers of patients with hip fracture from the patient's hospital admission through 3 months after discharge. The intervention includes education on hip fracture and basic rehabilitation during the first 1-2 days of hospitalization, guidance on home caregiving before discharge, and routine telephone or WeChat follow-up once weekly after discharge. Both the control and experimental groups receive this intervention.

Sperimentale: Usual Care Plus Family-Centered Empowerment Model Intervention

Primary family caregivers receive usual orthopedic care guidance and follow-up plus a structured Family-Centered Empowerment Model intervention from admission through 3 months after discharge. The program includes: (1) within 24 hours of admission, a caregiving manual and a group discussion addressing perceived threat (about 30 minutes); (2) during hospital days 1-7, two individual hands-on caregiving skills and scenario-based simulation sessions to strengthen self-efficacy (about 40 minutes each); (3) from day 8 to discharge, two sessions involving family participation in care planning and sharing caregiving experiences to support self-esteem (about 30 minutes each); and (4) after discharge, five targeted follow-up contacts and two online caregiving experience-sharing sessions for process and outcome evaluation.

Usual orthopedic care guidance and follow-up are provided to primary family caregivers of patients with hip fracture from the patient's hospital admission through 3 months after discharge. The intervention includes education on hip fracture and basic rehabilitation during the first 1-2 days of hospitalization, guidance on home caregiving before discharge, and routine telephone or WeChat follow-up once weekly after discharge. Both the control and experimental groups receive this intervention.

Primary family caregivers of patients with hip fracture receive a four-stage Family-Centered Empowerment Model program in addition to usual care, from the patient's admission through 3 months after discharge: (1) perceived threat: a standardized caregiving manual and group discussion within 24 hours of admission (about 30 minutes); (2) self-efficacy: two individual hands-on caregiving skills and scenario-based simulation sessions during hospital days 1-7 (about 40 minutes each); (3) self-esteem: two sessions involving family participation in care planning and sharing caregiving experiences from day 8 to discharge (about 30 minutes each); and (4) process and outcome evaluation: five targeted follow-up contacts and two online caregiving experience-sharing sessions after discharge through 3 months. This program is provided only to the experimental group.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Caregiver Burden Measured by the Zarit Burden Interview (ZBI)
Lasso di tempo: aseline, Periprocedural, 1 month, 3 months

Caregiver burden is assessed using the 22-item Zarit Burden Interview (ZBI). Each item is scored from 0 to 4, and item scores are summed to produce a total score ranging from 0 to 88. Higher scores indicate greater caregiver burden. Total scores are assessed at baseline, hospital discharge, and 1 and 3 months after discharge.

aseline, Periprocedural, 1 month, 3 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

5 novembre 2026

Completamento primario (Stimato)

5 maggio 2027

Completamento dello studio (Stimato)

5 maggio 2027

Date di iscrizione allo studio

Primo inviato

1 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 novembre 2026

Primo Inserito (Effettivo)

13 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • KY-2026-113

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified individual participant data underlying the published study results, together with a data dictionary, will be made available to qualified researchers upon reasonable request. Data access will require a written research proposal describing the intended analyses, review by the study team, and compliance with applicable institutional and ethics requirements. Any additional participant consent required for the proposed use will be obtained before sharing. Names, contact details, and other direct identifiers will not be shared.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .